WALLACE Trademark

Trademark Overview

On Thursday, August 15, 2013, a trademark application was filed for WALLACE with the United States Patent and Trademark Office. The USPTO has given the WALLACE trademark a serial number of 86039297. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 30, 2022. This trademark is owned by Wallace Pharmaceuticals Inc.. The WALLACE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, namely, an anti-inflammatory; pharmaceutical for the treatment of mastocytosis; pharmaceutical for the treatment of itching of the eye
wallace

General Information

Serial Number86039297
Word MarkWALLACE
Filing DateThursday, August 15, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 30, 2022
Registration Number4918568
Registration DateTuesday, March 15, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 5, 2013

Trademark Statements

Goods and ServicesPharmaceutical, namely, an anti-inflammatory; pharmaceutical for the treatment of mastocytosis; pharmaceutical for the treatment of itching of the eye

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 30, 2022
Primary Code005
First Use Anywhere DateThursday, March 10, 2011
First Use In Commerce DateThursday, March 10, 2011

Trademark Owner History

Party NameWallace Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameWallace Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873
Party NameWallace Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerset, NJ 08873

Trademark Events

Event DateEvent Description
Friday, September 30, 2022CANCELLED SEC. 8 (6-YR)
Monday, March 15, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 15, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, February 9, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 8, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, January 10, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, November 24, 2015USE AMENDMENT FILED
Tuesday, November 24, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, July 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 8, 2015SOU EXTENSION 3 GRANTED
Monday, June 29, 2015SOU EXTENSION 3 FILED
Monday, June 29, 2015TEAS EXTENSION RECEIVED
Thursday, February 19, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 18, 2015SOU EXTENSION 2 GRANTED
Wednesday, December 31, 2014SOU EXTENSION 2 FILED
Tuesday, February 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 31, 2014TEAS EXTENSION RECEIVED
Monday, October 6, 2014ASSIGNED TO EXAMINER
Wednesday, July 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 30, 2014SOU EXTENSION 1 GRANTED
Monday, June 30, 2014SOU EXTENSION 1 FILED
Monday, June 30, 2014TEAS EXTENSION RECEIVED
Tuesday, December 31, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, October 16, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 23, 2013ASSIGNED TO EXAMINER
Friday, August 23, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 19, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

wallace pharmaceutical treatment itching mastocytosis inflammatory namely anti